Adapting Neurological Care Amid COVID-19

As the ongoing battle against the spread of COVID-19 continues, the medical community is learning more about the disease and at-risk populations by the day. Many symptoms and comorbidities associated with neurologic disorders place patients, especially those in the neuromuscular disease community, within those high-risk categories established by the Centers for Disease Control and Prevention […]

UF Researcher Among Muscular Dystrophy Association Strategic Medical Advisory Team

The Muscular Dystrophy Association (MDA) announced the formation of its formal Medical Advisory Team who provide MDA with strategic guidance on issues that impact research and clinical care for people living with muscular dystrophy, amyotrophic lateral sclerosis (ALS) and related neuromuscular disorders – more than 43 diseases. Each of the team members is a leading […]